Chemokine (C-X-C Motif) Ligand 17 (CXCL17) Kits ELISA

Human Chemokine (C-X-C Motif) Ligand 17 (CXCL17) interaction partners

1. Study demonstrates that breast cancer cells secrete CXCL17, which increases the accumulation of CD11b+Gr-1+ myeloid-derived suppressor cells (MDSCs) in the lungs. CXCL17 increases MDSCs PDGF-BB secretion which contributes to MDSC-mediated angiogenesis in the lung metastatic niche and colonization of breast cancer. Patients with high levels of CXCL17 have shorter distant metastasis-free and overall survival rates.

2. epithelial and sputum miR-221-3p are novel biomarkers for airway eosinophilic inflammation in asthma. Decreased epithelial miR-221-3p may protect against airway eosinophilic inflammation by upregulating anti-inflammatory chemokine CXCL17.

3. Upregulation of CXCL17 expression was observed in hepatocellular carcinoma (HCC), which correlated with poorer histological stages and outcomes. Elevation of CXCL17 expression promoted proliferation, invasion, and migration and decreased autophagy the LKB1-AMPK pathway.

4. High Lymph node CXCL17 messenger RNA is associated with colon cancer.

5. High expression of CXCL17 correlates with shorter overall survival of breast cancer patients.CXCL17 interacts with CXCR8 in breast cancer cells.

6. CXCL17 attenuates Imiquimod -induced psoriasis-like skin inflammation by recruiting myeloid-derived suppressor cells and regulatory T cells , which may be important for regulating excessive inflammation in psoriasis skin.

7. This article shows that GPR35 is the receptor of CXCL17.

8. CXCL17 production correlated with adverse immune infiltration and might be an important target for anti-HCC therapies.

9. We conclude that CXCL17 is an antimicrobial mucosal chemokine that may play a role in the pathogenesis of interstitial lung diseases

10. these results suggest that VCC-1 is involved in cisplatin-induced apoptosis of HepG2 cells, and also provides some evidence for VCC-1 as a potential cellular target for chemotherapy.

11. An Fc-fusion protein of 35kDa with a modified human immunoglobulin IgG1 Fc domain is capable of inhibiting CC chemokine-induced calcium flux, chemotaxis, and beta-arrestin recruitment in primary macrophages and transfected cells.

12. Immune surveillance occurs during the early intraepithelial stages of human pancreatic carcinogenesis and is mediated by expression of CXCL17 and ICAM2.

13. DMC induces migration of monocytes and immature dendritic cells. Expression studies show that DMC is constitutively expressed in lung, suggesting a potential role for DMC in recruiting monocytes and dendritic cells from blood into lung parenchyma

14. VCC1 plays a role in angiogenesis and possibly in the development of tumors in some tissue types

15. These results strongly suggest that VCC-1 plays an important role in hepatocellular carcinoma cell invasion and tumor growth.

Mouse (Murine) Chemokine (C-X-C Motif) Ligand 17 (CXCL17) interaction partners

1. CXCL17 attenuates Imiquimod -induced psoriasis-like skin inflammation by recruiting myeloid-derived suppressor cells and regulatory T cells , which may be important for regulating excessive inflammation in psoriasis skin.

2. CXCL17 is a novel macrophage chemoattractant that operates in mucosal tissues as a major regulator of inflammatory responses.

3. These results suggest that aberrant expression of CXCL17 in tumor cells recruits immature myeloid-derived cells and promotes tumor progression through angiogenesis.

4. VCC-1 plays a role in angiogenesis and possibly in the development of tumors in some tissue types[VCC-1]